These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 24828352

  • 1. Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.
    Trott M, Weiβ S, Antoni S, Koch J, von Briesen H, Hust M, Dietrich U.
    PLoS One; 2014; 9(5):e97478. PubMed ID: 24828352
    [Abstract] [Full Text] [Related]

  • 2. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S, Kumar R, Deshpande S, Samal S, Shrivastava T, Boliar S, Bansal M, Chaudhary NK, Srikrishnan AK, Murugavel KG, Solomon S, Simek M, Koff WC, Goyal R, Chakrabarti BK, Bhattacharya J.
    J Virol; 2016 Jan 13; 90(7):3446-57. PubMed ID: 26763999
    [Abstract] [Full Text] [Related]

  • 3. A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies.
    Davis-Gardner ME, Alfant B, Weber JA, Gardner MR, Farzan M.
    mBio; 2020 Jan 14; 11(1):. PubMed ID: 31937648
    [Abstract] [Full Text] [Related]

  • 4. A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.
    Silver ZA, Dickinson GM, Seaman MS, Desrosiers RC.
    J Virol; 2019 May 15; 93(10):. PubMed ID: 30842322
    [Abstract] [Full Text] [Related]

  • 5. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
    Qualls ZM, Choudhary A, Honnen W, Prattipati R, Robinson JE, Pinter A.
    J Virol; 2018 Mar 01; 92(5):. PubMed ID: 29237828
    [Abstract] [Full Text] [Related]

  • 6. Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.
    Blattner C, Lee JH, Sliepen K, Derking R, Falkowska E, de la Peña AT, Cupo A, Julien JP, van Gils M, Lee PS, Peng W, Paulson JC, Poignard P, Burton DR, Moore JP, Sanders RW, Wilson IA, Ward AB.
    Immunity; 2014 May 15; 40(5):669-80. PubMed ID: 24768348
    [Abstract] [Full Text] [Related]

  • 7. Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11.
    Moyo T, Ereño-Orbea J, Jacob RA, Pavillet CE, Kariuki SM, Tangie EN, Julien JP, Dorfman JR.
    J Virol; 2018 Jul 15; 92(14):. PubMed ID: 29618644
    [Abstract] [Full Text] [Related]

  • 8. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
    Gift SK, Leaman DP, Zhang L, Kim AS, Zwick MB.
    J Virol; 2017 Dec 15; 91(24):. PubMed ID: 28978711
    [Abstract] [Full Text] [Related]

  • 9. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.
    Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS.
    Virology; 2007 Jun 20; 363(1):79-90. PubMed ID: 17306322
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
    Castillo-Menendez LR, Witt K, Espy N, Princiotto A, Madani N, Pacheco B, Finzi A, Sodroski J.
    J Virol; 2018 Jun 15; 92(12):. PubMed ID: 29618643
    [Abstract] [Full Text] [Related]

  • 11. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
    Louis JM, Aniana A, Lohith K, Sayer JM, Roche J, Bewley CA, Clore GM.
    PLoS One; 2014 Jun 15; 9(8):e104683. PubMed ID: 25105806
    [Abstract] [Full Text] [Related]

  • 12. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM, Stryjewski BL, Broder CC, Hoxie JA, Mascola JR, Earl PL, Doms RW.
    J Virol; 1996 Feb 15; 70(2):753-62. PubMed ID: 8551612
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y, O'Dell S, Turner HL, Chiang CI, Lei L, Guenaga J, Wilson R, Martinez-Murillo P, Doria-Rose N, Ward AB, Mascola JR, Wyatt RT, Karlsson Hedestam GB, Li Y.
    J Virol; 2017 Nov 01; 91(21):. PubMed ID: 28835491
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.